Insmed | Rörelsekostnader



Operating Expenses Ändra Datum
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Cytokinetics USD 155.97M 14.7M 2024-12
DBV Technologies USD 31.4M 3.6M 2024-09
Dynavax Technologies USD 73.66M 3.12M 2024-12
Gilead Sciences USD 5.12B 1.54B 2024-12
Insmed USD 334.86M 28M 2024-12
Novartis USD 10.15B 579M 2024-12
Regeneron Pharmaceuticals USD 2.8B 26.53B 2024-12
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Insmed Rörelsekostnader - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.